Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-040723

CEO and CFO bought 5,000 shares at $10.17 ($50,838)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-11-10 Purchase +5,000 $10.17 $50,838 5,312,677 D
Open-market purchases · 5,000 sh · avg $10.17 · $50,838
Loading xslF345X05/ownership.xml…